SSC 08.04 - Should Caplacizumab Be Used up Front in All Patients With Auto-Immune Thrombotic Thrombocytopenic Purpura (iTTP): Point/Counterpoint

Sunday, July 10, 2022

4:55 PM – 5:05 PM

Location: S11B

Presentation Format: In-Person

Speaker(s)

Paul Knoebl, MD

Professor
Department of Medicine 1, Division of Hematology and Hemostasis, Medical University of Vienna, Vienna, Austria
Vienna, Wien, Austria